Zura Bio
ZURA
33 hedge funds and large institutions have $80.5M invested in Zura Bio in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
36% more capital invested
Capital invested by funds: $59M → $80.5M (+$21.4M)
8% less funds holding
Funds holding: 36 → 33 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$2.99M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.54M |
| 3 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$1.19M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$1.19M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$1.94M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$465K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$239K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$210K |
| 5 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$181K |
ZURA Hedge Fund Activity: Q3 2022 in Review
33 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2022, worth a combined $80.5M — up 36% from $59M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ZURA and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 9 added.
The largest buyer was Glazer Capital LLC, adding an estimated $2.99M. The largest seller was Basso Capital Management, exiting entirely with an estimated $1.94M sold.
- 33 institutional investors held Zura Bio (ZURA) as of Q3 2022, down from 36 in Q2 2022.
- Funds reported $80.5M of Zura Bio stock for Q3 2022, up 36% quarter-over-quarter.
- 3 funds opened new Zura Bio positions in Q3 2022 and 6 closed out, a net change of -3 holders.
- The largest Zura Bio buyer in Q3 2022 was Glazer Capital LLC, an estimated $2.99M added.
- The largest Zura Bio seller in Q3 2022 was Basso Capital Management, an estimated $1.94M sold.
Based on aggregated 13F filings for Q3 2022.